Noninvasive Ventilation in an Intermediate-Care-Unit
Autor(a) principal: | |
---|---|
Data de Publicação: | 2006 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://revista.spmi.pt/index.php/rpmi/article/view/1628 |
Resumo: | Background: Non-Invasive Ventilation (NIV) is a method of alveolar ventilation, which has been shown to be effi cient and safe in patients with chronic or acute respiratory insuffi ciency. Our experience with NIV, in a Medical Intermediate-Care-Unit, over a 2-year period, is presented.Methods: A retrospective study of 66 patients who were treated with NIV, in the medical intermediate care unit (MICU) of the Garcia de Orta Hospital, between January of 2001 and December 2002 was performed. Epidemiological, clinical and laboratory data were analysed.Results: Of 315 patients admitted to the MICU, 66 (20%) were ventilated non-invasively. Fifty-three percent were male and the mean age was 68 years. The main underlying conditions leading to NIV were Chronic Obstructive Pulmonary Disease (COPD) in 33 patients (50%), Pneumonia in 12 (18%), Congestive Heart Failure (CHF) in 9 (14%), Post-Extubation-Syndrome (PES) in 6 (9%), Pickwick Disease in 4 (6%), Kyphoscoliosis and Amyotrophic Lateral Sclerosis (ALS) one of each. The interface most commonly selected for NVI was the face mask (98%). After 48 hours of ventilation, signifi cant improvement of gas exchange was achieved in 61% of patients. Nine patients deteriorated clinically within this period, of whom, three needed to be transferred to an intensive care unit for invasive ventilation and 3 patients died. The mean length of stay in the MICU was 8.5 days, with a mean time of ventilation of 6.4 days ( 8.8 in CHF, 7 in PES, 6 in COPD and 3.8 in Pneumonia). Invasive ventilation was necessary in 11 patients, 4 with COPD, 3 with pneumonia, 2 with CHF, 1 with Pickwick disease and 1 with PES. Nine percent of the patients, all suffering from COPD, continued NIV after discharge on an outpatient basis. The overall mortality of patients undergoing NIV was 21%.Conclusion and Discussion: NIV lead to signifi cant improvement in gas exchange in 61% of patients, within the fi rst 48 hours. Patients with COPD, CHF and pneumonia had the highest benefi t, the latter requiring the shortest time of ventilation. |
id |
RCAP_a359e5eaa2ec32b28a747b329b5ea0c0 |
---|---|
oai_identifier_str |
oai:oai.revista.spmi.pt:article/1628 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Noninvasive Ventilation in an Intermediate-Care-UnitVentilação Não Invasiva numa Unidade de Cuidados IntermédiosVentilação não invasivaunidade cuidados intermédiosdoença pulmonar obstrutiva crónicanon invasive ventilationintermediate care unitchronic obstructive pulmonary diseaseBackground: Non-Invasive Ventilation (NIV) is a method of alveolar ventilation, which has been shown to be effi cient and safe in patients with chronic or acute respiratory insuffi ciency. Our experience with NIV, in a Medical Intermediate-Care-Unit, over a 2-year period, is presented.Methods: A retrospective study of 66 patients who were treated with NIV, in the medical intermediate care unit (MICU) of the Garcia de Orta Hospital, between January of 2001 and December 2002 was performed. Epidemiological, clinical and laboratory data were analysed.Results: Of 315 patients admitted to the MICU, 66 (20%) were ventilated non-invasively. Fifty-three percent were male and the mean age was 68 years. The main underlying conditions leading to NIV were Chronic Obstructive Pulmonary Disease (COPD) in 33 patients (50%), Pneumonia in 12 (18%), Congestive Heart Failure (CHF) in 9 (14%), Post-Extubation-Syndrome (PES) in 6 (9%), Pickwick Disease in 4 (6%), Kyphoscoliosis and Amyotrophic Lateral Sclerosis (ALS) one of each. The interface most commonly selected for NVI was the face mask (98%). After 48 hours of ventilation, signifi cant improvement of gas exchange was achieved in 61% of patients. Nine patients deteriorated clinically within this period, of whom, three needed to be transferred to an intensive care unit for invasive ventilation and 3 patients died. The mean length of stay in the MICU was 8.5 days, with a mean time of ventilation of 6.4 days ( 8.8 in CHF, 7 in PES, 6 in COPD and 3.8 in Pneumonia). Invasive ventilation was necessary in 11 patients, 4 with COPD, 3 with pneumonia, 2 with CHF, 1 with Pickwick disease and 1 with PES. Nine percent of the patients, all suffering from COPD, continued NIV after discharge on an outpatient basis. The overall mortality of patients undergoing NIV was 21%.Conclusion and Discussion: NIV lead to signifi cant improvement in gas exchange in 61% of patients, within the fi rst 48 hours. Patients with COPD, CHF and pneumonia had the highest benefi t, the latter requiring the shortest time of ventilation.A ventilação não invasiva (VNI) é um modo de ventilação mecânica alveolar, que tem sido utilizada de forma crescente em situações de insuficiência respiratória aguda e crónica agudizada. Objectivo: Demonstrar a experiência com a VNI, numa Unidade de Cuidados Intermédios durante 2 anos.Métodos: Foram analisados retrospectivamente dados epidemiológicos, clínicos e laboratoriais de 66 doentes, submetidos a VNI, admitidos entre Janeiro de 2001 e Dezembro de 2002, numa unidade de cuidados intermédios - Unidade Médica Diferenciada (UMD), do Hospital Garcia de Orta (HGO).Resultados: Em 315 doentes internados na UMD, 66 (20%) foram ventilados não invasivamente. A maioria era do sexo masculino (53%), com idade média de 68 anos. As patologias, que motivaram a VNI, foram a Doença Pulmonar Obstrutiva Crónica (DPOC) agudizada em 33 doentes (50%), a Pneumonia em 12 (18%), a Insuficiência Cardíaca (IC) em 9 (14%), a Síndrome Pós-Extubação (SPE) em 6 (9%), a Síndrome de Pickwick em 4 (6%) e a Cifoescoliose e a Esclerose Lateral Amiotrófica (ELA) num doente cada. O tipo de interface doente/ventilador mais utilizado foi a máscara facial (98%). Às 48 horas de ventilação, verificou-se melhoria das trocas gasosas em 40 doentes (61%) e agravamento em 9, dos quais, 3 necessitaram de ventilação invasiva, e outros 3 faleceram. Os doentes estiveram ventilados numa média de 6.4 dias, 10 na síndrome de Pickwick, 8.8 na IC, 7 na SPE, 6 na DPOC e 3.8 na pneumonia; com um tempo médio de internamento na UMD de 8.5 dias. Houve necessidade de ventilação invasiva em 11 doentes, 4 doentes com DPOC, 3 com pneumonia, 2 com IC, 1 com síndrome Pickwick e 1 com SPE. Tiveram alta com indicação para manter VNI em ambulatório 9% dos doentes, todos com DPOC. A taxa de mortalidade foi de 21%.Conclusão e Discussão: A VNI demonstrou ser eficaz com melhoria gasimétrica em 61 % dos doentes às 48 horas. O maior benefício verificou-se nos doentes com DPOC, com insuficiência cardíaca e com pneumonia, estes últimos com um número reduzido de dias de ventilação.Sociedade Portuguesa de Medicina Interna2006-06-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://revista.spmi.pt/index.php/rpmi/article/view/1628Internal Medicine; Vol. 13 No. 2 (2006): Abril/ Junho; 73-78Medicina Interna; Vol. 13 N.º 2 (2006): Abril/ Junho; 73-782183-99800872-671Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revista.spmi.pt/index.php/rpmi/article/view/1628https://revista.spmi.pt/index.php/rpmi/article/view/1628/1095Felgueiras, JoanaLohmann, CorinnaDelerue, FranciscaBarata, Joséinfo:eu-repo/semantics/openAccess2023-02-25T06:11:03Zoai:oai.revista.spmi.pt:article/1628Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:47:16.662309Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Noninvasive Ventilation in an Intermediate-Care-Unit Ventilação Não Invasiva numa Unidade de Cuidados Intermédios |
title |
Noninvasive Ventilation in an Intermediate-Care-Unit |
spellingShingle |
Noninvasive Ventilation in an Intermediate-Care-Unit Felgueiras, Joana Ventilação não invasiva unidade cuidados intermédios doença pulmonar obstrutiva crónica non invasive ventilation intermediate care unit chronic obstructive pulmonary disease |
title_short |
Noninvasive Ventilation in an Intermediate-Care-Unit |
title_full |
Noninvasive Ventilation in an Intermediate-Care-Unit |
title_fullStr |
Noninvasive Ventilation in an Intermediate-Care-Unit |
title_full_unstemmed |
Noninvasive Ventilation in an Intermediate-Care-Unit |
title_sort |
Noninvasive Ventilation in an Intermediate-Care-Unit |
author |
Felgueiras, Joana |
author_facet |
Felgueiras, Joana Lohmann, Corinna Delerue, Francisca Barata, José |
author_role |
author |
author2 |
Lohmann, Corinna Delerue, Francisca Barata, José |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Felgueiras, Joana Lohmann, Corinna Delerue, Francisca Barata, José |
dc.subject.por.fl_str_mv |
Ventilação não invasiva unidade cuidados intermédios doença pulmonar obstrutiva crónica non invasive ventilation intermediate care unit chronic obstructive pulmonary disease |
topic |
Ventilação não invasiva unidade cuidados intermédios doença pulmonar obstrutiva crónica non invasive ventilation intermediate care unit chronic obstructive pulmonary disease |
description |
Background: Non-Invasive Ventilation (NIV) is a method of alveolar ventilation, which has been shown to be effi cient and safe in patients with chronic or acute respiratory insuffi ciency. Our experience with NIV, in a Medical Intermediate-Care-Unit, over a 2-year period, is presented.Methods: A retrospective study of 66 patients who were treated with NIV, in the medical intermediate care unit (MICU) of the Garcia de Orta Hospital, between January of 2001 and December 2002 was performed. Epidemiological, clinical and laboratory data were analysed.Results: Of 315 patients admitted to the MICU, 66 (20%) were ventilated non-invasively. Fifty-three percent were male and the mean age was 68 years. The main underlying conditions leading to NIV were Chronic Obstructive Pulmonary Disease (COPD) in 33 patients (50%), Pneumonia in 12 (18%), Congestive Heart Failure (CHF) in 9 (14%), Post-Extubation-Syndrome (PES) in 6 (9%), Pickwick Disease in 4 (6%), Kyphoscoliosis and Amyotrophic Lateral Sclerosis (ALS) one of each. The interface most commonly selected for NVI was the face mask (98%). After 48 hours of ventilation, signifi cant improvement of gas exchange was achieved in 61% of patients. Nine patients deteriorated clinically within this period, of whom, three needed to be transferred to an intensive care unit for invasive ventilation and 3 patients died. The mean length of stay in the MICU was 8.5 days, with a mean time of ventilation of 6.4 days ( 8.8 in CHF, 7 in PES, 6 in COPD and 3.8 in Pneumonia). Invasive ventilation was necessary in 11 patients, 4 with COPD, 3 with pneumonia, 2 with CHF, 1 with Pickwick disease and 1 with PES. Nine percent of the patients, all suffering from COPD, continued NIV after discharge on an outpatient basis. The overall mortality of patients undergoing NIV was 21%.Conclusion and Discussion: NIV lead to signifi cant improvement in gas exchange in 61% of patients, within the fi rst 48 hours. Patients with COPD, CHF and pneumonia had the highest benefi t, the latter requiring the shortest time of ventilation. |
publishDate |
2006 |
dc.date.none.fl_str_mv |
2006-06-30 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://revista.spmi.pt/index.php/rpmi/article/view/1628 |
url |
https://revista.spmi.pt/index.php/rpmi/article/view/1628 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://revista.spmi.pt/index.php/rpmi/article/view/1628 https://revista.spmi.pt/index.php/rpmi/article/view/1628/1095 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Medicina Interna |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Medicina Interna |
dc.source.none.fl_str_mv |
Internal Medicine; Vol. 13 No. 2 (2006): Abril/ Junho; 73-78 Medicina Interna; Vol. 13 N.º 2 (2006): Abril/ Junho; 73-78 2183-9980 0872-671X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1817552902561988608 |